41st Annual General Meeting of Ibn Sina Pharmaceutical Industries PLC

The 41^th Annual General Meeting of The IBN SINA Pharmaceutical Industry PLC is held today through Digital (Virtual) Platform. Kazi Harun or Rashid Hon’ble Chairman of the Company presided over the meeting.

A large number of Shareholders, Managing Director Prof. Dr. A. K. M Sadrul Islam including Founding Director Prof. Abu Nasser Muhammad Abduz Zaher and other Hon’ble Directors, Chairman Audit Committee, Chairman NRC, Statutory Auditors, Compliance Auditors, Independent Scrutinizer and Company Secretary also attended the virtual AGM. The meeting started at 9:30 am by recitation from the Holy Quran with meanings.  

The Directors’ Report, Auditors’ Report and Audited Financial Statements were presented in the AGM for the Financial Year, 2024-2025.

The AGM approved 64% Cash Dividend after evaluating the financial report for the year 2024-2025 of the Company.

Prof. Dr. A K M Sadrul Islam, Managing Director, delivered his speech and also replied to the Hon’ble Shareholders’ various questions.

Kazi Harun or Rashid and Prof. Dr. A K M Sadrul Islam were re-elected as Director by rotation.

The Company had made a significant contribution in the year under review towards the National Exchequer by paying Tk. 218,06,66,966 (Two hundred eighteen crore six lac sixty six thousand nine hundred sixty six) as Income Tax, VAT and other applicable Taxes.

As per the Bangladesh Labour Laws, the Company has transferred 5% of the profit, i.e. Tk. 4,33,58,391/-

 (Four crore thirty-three lac fifty-eight thousand three hundred and ninety-one) to the Workers’ Profit Participation Fund (WPPF).

The meeting was ended with a vote of thanks to and from the Chairman of the Company by praying for the blessings of the Almighty Allah to the human being at large.